Ocera, Genentech, Roche deal

On Dec. 17, 2013, Ocera said it will transfer equipment and materials related to its Macrocyclic Template Chemistry (MATCH) drug

Read the full 206 word article

How to gain access

Continue reading with a
two-week free trial.